POLY STUDIO IS NOW CERTIFIED FOR MICROSOFT TEAMS

It seems like every photo shown of a business in action these days features a bunch of people in a huddle room, looking productive – just like our own Poly beauty shot below. But the technology that is IN the room really matters most to the people who are joining remotely – the people NOT in the room: Your sales team joining a Microsoft Teams meeting from the road. Your CFO joining a budgeting meeting from his cabin in the mountains. Your flexible workers joining small team brainstorms or regular staff. What you have in your huddle rooms can either make people more productive by making them more included … or can frustrate them with bad audio, choppy video or cameras pointed anywhere but at the speaker. If you’re moving to Teams, you want to be moving forward, now, with the best experiences. Poly’s new Studio USB video bar – now certified for Teams – can help.

Spotlight

bluebird bio

We are leading the gene therapy revolution. Our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing us with the potential to treat, and hopefully cure, a broad range of serious diseases.

OTHER ARTICLES
MedTech

How to Choose a Reliable Biotech Clinical Trial Management System?

Article | July 11, 2022

Introduction The medical and life-science industries are experiencing a robust transformation with the increasing prevalence of various types of diseases, including infectious diseases, chronic disorders, and acute conditions around the world. As a result, a significant rise in demand for more effective therapeutic drugs and bionics is being witnessed, leading to a swift increase in the number of clinical trials. For a successful trial, it is important for biotech companies to ensure the data submitted to regulatory bodies regarding clinical trials is accurate, reliable, and definitive from an ethical point of view. A reliable clinical trial management system plays a vital role in collecting, monitoring, and managing clinical data. The availability of high-quality clinical data also helps clinical research institutions make efficient treatment decisions and provide proper patient care. Hence, a number of biotech companies and research organizations are focusing on leveraging innovative clinical trial management solutions to handle a large amount of data, particularly in multi-center trials, and generate reliable, high-quality, and statistically sound data from clinical trials. However, selecting the most appropriate and reliable clinical trial management system is vital for the clinical trial's success. Let's see some of the steps that will assist these firms in choosing the right CTMS. Key Steps for Selecting Right Biotech Clinical Trial Management System Prioritize Study Needs Considering and prioritizing study needs is a crucial step in choosing the most reliable clinical trial management system for biotech companies. Prioritizing helps them to identify a solution that improves the study's quality and removes uncertainty for researchers when faced with difficult choices. Hence, biotech and life-science organizations should choose a clinical trial system that is simple to use, well-organized, and suitably designed to minimize the number of clicks required to complete a task. Select CTMS with Multiple Integrations Integrated clinical trial management systems provide the best value for the companies’ funds as they guarantee the smooth functioning of research protocols. In addition, integrations are necessary to fully understand the importance and advantages of clinical trial management software for ensuring smooth transitions between site management and data collection. Biotech and clinical research should look for CTMS platforms that can integrate with electronic medical record (EMR) platforms and clinical research process content (CRPC) billing grids. This will allow them to use the same billing designations and ensure compliance while minimizing the need for duplicate processes. Ensure System Compliance and Security Clinical research organizations need to adhere to a plethora of complex regulations in order to ensure compliance with one of the most challenging environments of principles, which is information security and privacy. Security and system compliance are vital aspects of choosing the right CTMS solutions for biotech firms as they assist in building trust and form a part of the system’s duties. While selecting CTMS systems, it is essential for companies engaged in clinical research to ensure that these platforms are able to configure both, group and individual permissions, along with having a data backup and recovery plan for hosted systems. This will allow companies to assess the privacy and security implications of research and anticipate complications that may arise in each phase of the project. Assess the Scalability Choosing a scalable CTMS that can accommodate various types of fluctuations and expansions enables biotech and clinical firms to quickly adapt to fast-changing trends and demand spikes while reducing maintenance costs and enhancing user agility. As scalability also means secure and expanded data storage, these businesses should instead use SaaS solutions than manually manage an ever-growing collection of hard drives. The right CTMS ensures accommodating the firm’s availability requirements without incurring the capital costs associated with expanding a physical infrastructure. The Closing Thought A well-executed and successful clinical trial involves multiple stages and processes. Several quality controls and stringent adherence to regulations are essential for the steps, along with efficient cross-departmental processes and procedures. Incorporating the right CTMS paves the way for paperless data collection, regulatory filing, and fiscal management tools for biotech researchers and administrative personnel.

Read More
MedTech

Next-Gen Genetics Cancer Therapies Creating Investment Prospects

Article | September 22, 2022

Genetic therapeutics such as genetic engineering and gene therapy are increasingly emerging as one of the most influential and transformed biotechnological solutions around the globe in recent times. These genetic solutions are being assessed across various medical domains, including cancer treatment, neurology, oncology, and ophthalmology. Citing the trend, the genetics industry is estimated to experience a tsunami of approvals, with over 1,000 cell and gene therapy clinical trials currently underway and over 900 companies worldwide focusing on these cutting-edge therapies. Growing Cancer Encourages Advancements in Genetic Technologies With the surging cases of cancers such as leukemias, carcinomas, lymphomas, and others, patients worldwide are increasing their spending on adopting novel therapeutic solutions for non-recurring treatment of the disease, such as gene therapy, genetic engineering, T-cell therapy, and gene editing. As per a study by the Fight Cancer Organization, spending on the treatment of cancer increased to $200.7 billion, and the amount is anticipated to exceed $245 billion by the end of 2030. Growing revenue prospects are encouraging biotechnology and biopharmaceutical companies to develop novel genetic solutions for cancer treatment. For instance, Bristol-Myers Squibb K.K., a Japanese pharmaceutical company, introduced a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy, Abecma, for the treatment of relapsed or refractory (R/R) multiple myeloma in 2022. Amid a New Market: Genetics Will Attract Massive Investments Despite several developments and technological advancements, genetics is still considered to be in a nascent stage, providing significant prospects for growth to the companies that are already operating in the domain. Genetics solutions such as gene therapies, gene editing, and T-cell immunotherapy are emerging as highly active treatments across various medical fields, resulting in increasing research and development activities across the domain, drawing significant attention from investors. Given the potential of genetic treatments and the focus on finding new ways to treat cancer and other related diseases, it's easy to understand why companies are investing in the domain. For instance, Pfizer has recently announced an investment of around $800 million to construct development facilities supporting gene therapy manufacturing from initial preclinical research through final commercial-scale production. Due to these advancements, cell and gene therapies are forecast to grow from $4 billion annually to more than $45 billion, exhibiting growth at a 63% CAGR. The Future of Genetics Though there is a significant rise in advancement in genetic technologies and developments, the number of approved genetic treatments remains extremely small. However, with gene transfer and CRISPR solutions emerging as new modalities for cancer treatment, the start-up companies will attract a growing amount and proportion of private and public investments. This is expected present a tremendous opportunity for biopharma and biotechnology investors to help fund and benefit from the medical industry's shift from traditional treatments to cutting-edge genetic therapeutics in the coming years.

Read More
MedTech

5 Biotech Stocks Winning the Coronavirus Race

Article | July 20, 2022

There are quite a few companies that have found ways to grow their business during the ongoing COVID-19 pandemic. This is especially true for a number of biotechs now working on developing a potential treatment for, or vaccine against, the virus; shares of such companies have largely surged over the past couple of months. Although many of these treatments and vaccines are still have quite a way to go before they're widely available, it's still worth taking some time to look through what's going on in the COVID-19 space right now. Here are five biotech stocks that are leading the way when it comes to addressing COVID-19. Regeneron Pharmaceuticals (NASDAQ:REGN) wasn't among the initial wave of companies to announce a potential COVID-19 drug. However, investor excitement quickly sent shares surging when the company announced that its rheumatoid arthritis drug, Kevzara, could help treat COVID-19 patients.

Read More
Medical

Laboratory Information Management System for Biotech Labs: Significance & Benefits

Article | August 16, 2022

If you have ever visited the testing laboratory of a large biotechnology company, you will be aware that managing the laboratory's operations single-handedly is no easy task. The greater the size of a lab, the more research and testing activities it must accommodate. A variety of diagnostic tests are prescribed for patients in order to detect various diseases. For example, it may include blood glucose testing for diabetics, lipid panel, or liver panel tests for evaluating cardiac risk and liver function, cultures for diagnosing infections, thyroid function tests, and others. Laboratory management solutions such as laboratory information management systems (LIMS) and other software play a significant role in managing various operational data at biotech laboratories. It is one of the important types of software developed to address thedata management and regulatory challenges of laboratories. The software enhances the operational efficiency of biotech labs by streamlining workflows, proper record-keeping, and eradicating the need for manually maintaining data. What Are the Benefits of Laboratory Information Management Software in Biotechnology? As the trends of digitization and technology continue to create deeper inroads into the biotechnology sector, a significant rise in the adoption of innovative medical software solutions, such as LIMS, is being witnessed for managing research data, testing reports, and post-research results globally. Here are a few reasons that are encouraging biotech facilities to adopt LIMS solutions Real-Time Data Collection and Tracking Previously, collecting and transporting samples was a tedious and time-consuming task. However, the adoption of LIMS with innovative tracking modules has made the job easier. The real-time sample tracking feature of LIMS has made it possible for personnel to collect the research data in real-time and manage and control the workflow with a few mouse clicks on the screen. Increase Revenue LIMS makes it possible to test workflows while giving users complete control over the testing process. A laboratory is able to collect data, schedule equipment maintenance or upgrades, enhance operational efficiency, and maintain a lower overhead with the help of the LIMS, thereby increasing revenue. Streamlined Workflow With its completion monitoring, LIMS speeds up laboratory workflows and keeps track of information. It assigns tasks to the specialist along with keeping a real-time track of the status and completion of each task. LIMS is integrated into the laboratory using lab information, which ultimately speeds up internal processes and streamlines the workflow. Automatic Data Exchange LIMS solutions store data in a centralized database. Automated transfer of data between departments and organizations is one of the major features of LIMS. Through its automated information exchange feature, LIMS improves internal operations, decreases the reporting time for data sharing, and assists in faster decision-making. Final Thoughts As the healthcare sector continues to ride the wave of digital transformation, biotech laboratories are emphasizing adopting newer technologies to keep up with the changes. Citing this trend, laboratory information management systems are becoming crucial for biotech and medical organizations for maintaining research data, instant reporting, and managing confidential, inventory, and financial data with centralized data storage.

Read More

Spotlight

bluebird bio

We are leading the gene therapy revolution. Our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing us with the potential to treat, and hopefully cure, a broad range of serious diseases.

Related News

€39M Series B to Fund Biopolymers for Surgery and Implants

Labiotech.eu | November 20, 2019

The French company Tissium has raised a €38.8M Series B round to fund the development of polymers that can be used to repair blood vessels and nerves. ontributing to the round were newcomers to Tissium such as the European Investment Fund and returning investors such as the investment bank Bpifrance and French life sciences VC firm Sofinnova Partners. Tissium, formerly known as Gecko Biomedical, develops polymers that can act as surgical glue or be 3D-printed as implants. The company has an EU-approved polymer glue that is used to seal blood vessels in surgery. Called Setalum, the glue sets when hit with a beam of light, making it easy for surgeons to apply and control it during complicated surgeries. In one clinical study, the glue halted bleeding in 85% of the enrolled patients.

Read More

Poly Introduces the Next Generation of Savi Wireless Headsets

Poly | September 18, 2019

Plantronics, Inc. (“Poly” – formerly Plantronics and Polycom) (NYSE: PLT), a global communications company that powers meaningful human connection and collaboration, today announced the next generation of the company’s lineup of popular Savi wireless headsets. The enhanced Savi Office and UC Series will offer more wearing styles, plus features to help with working in noisy office environments. “People will always need the ability to focus,” said Tamara Lane, director of product marketing, personal solutions, of Poly. “Open offices facilitate collaboration which is great for group problem-solving, but we all have our moments when we need to focus independently. The challenge is staying in the zone despite the buzz around you. We’ve updated our Savi 8200 Office and UC Series headsets to better address these needs.”

Read More

See What People are Saying about the Poly Studio USB Video Bar

Poly | November 13, 2019

“The Polycom Studio is fantastic because it gives organisations access to the flexible huddle room environments they need, without asking them to deal with complicated tools and technology. The Polycom Studio is a powerful piece of equipment, but it’s not complicated or daunting. Unlike other solutions on the market today, it’s designed to simply fade into the background, providing support you can rely on, without the complexity.” Polycom Studio offers several advanced features that set it apart from competing, similarly priced products, such as active speaker tracking and background noise suppression. Polycom Studio is, in fact, dead simple to install. Audio quality was outstanding. Video quality was equally good. It brings surprisingly powerful conferencing tools to any room that has a monitor/tv and a computer. Under $1000, it’s an excellent solution for any organization needing access to video conferencing

Read More

€39M Series B to Fund Biopolymers for Surgery and Implants

Labiotech.eu | November 20, 2019

The French company Tissium has raised a €38.8M Series B round to fund the development of polymers that can be used to repair blood vessels and nerves. ontributing to the round were newcomers to Tissium such as the European Investment Fund and returning investors such as the investment bank Bpifrance and French life sciences VC firm Sofinnova Partners. Tissium, formerly known as Gecko Biomedical, develops polymers that can act as surgical glue or be 3D-printed as implants. The company has an EU-approved polymer glue that is used to seal blood vessels in surgery. Called Setalum, the glue sets when hit with a beam of light, making it easy for surgeons to apply and control it during complicated surgeries. In one clinical study, the glue halted bleeding in 85% of the enrolled patients.

Read More

Poly Introduces the Next Generation of Savi Wireless Headsets

Poly | September 18, 2019

Plantronics, Inc. (“Poly” – formerly Plantronics and Polycom) (NYSE: PLT), a global communications company that powers meaningful human connection and collaboration, today announced the next generation of the company’s lineup of popular Savi wireless headsets. The enhanced Savi Office and UC Series will offer more wearing styles, plus features to help with working in noisy office environments. “People will always need the ability to focus,” said Tamara Lane, director of product marketing, personal solutions, of Poly. “Open offices facilitate collaboration which is great for group problem-solving, but we all have our moments when we need to focus independently. The challenge is staying in the zone despite the buzz around you. We’ve updated our Savi 8200 Office and UC Series headsets to better address these needs.”

Read More

See What People are Saying about the Poly Studio USB Video Bar

Poly | November 13, 2019

“The Polycom Studio is fantastic because it gives organisations access to the flexible huddle room environments they need, without asking them to deal with complicated tools and technology. The Polycom Studio is a powerful piece of equipment, but it’s not complicated or daunting. Unlike other solutions on the market today, it’s designed to simply fade into the background, providing support you can rely on, without the complexity.” Polycom Studio offers several advanced features that set it apart from competing, similarly priced products, such as active speaker tracking and background noise suppression. Polycom Studio is, in fact, dead simple to install. Audio quality was outstanding. Video quality was equally good. It brings surprisingly powerful conferencing tools to any room that has a monitor/tv and a computer. Under $1000, it’s an excellent solution for any organization needing access to video conferencing

Read More

Events